Home > Balance Sheet > AJANTA PHARMA

AJANTA PHARMA
Total Non-Current Liabilities

    Back to Balance Sheet
AJANTA PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for AJANTA PHARMA
Please provide your vote to see the results

AJANTA PHARMA Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Total Non-Current Liabilities ₹33 Cr₹42 Cr₹41 Cr₹177 Cr₹285 Cr

What is the latest Total Non-Current Liabilities ratio of AJANTA PHARMA ?

The latest Total Non-Current Liabilities ratio of AJANTA PHARMA is ₹33 Cr based on Mar2026 Consolidated results.
Year Total Non-Current Liabilities
Mar2026₹33 Cr
Mar2025₹42 Cr
Mar2024₹41 Cr
Mar2023₹177 Cr
Mar2022₹285 Cr

How is Total Non-Current Liabilities of AJANTA PHARMA Trending?

Years Total Non-Current Liabilities % Change
Mar2026 ₹33 Cr
-22.81
Mar2025 ₹42 Cr
3.21
Mar2024 ₹41 Cr
-76.99
Mar2023 ₹177 Cr
-37.77
Mar2022 ₹285 Cr -

Compare Total Non-Current Liabilities of peers of AJANTA PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AJANTA PHARMA ₹44,358.8 Cr -0.8% -0.6% 40% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹444,717.0 Cr 1% -3.3% 13.1% Stock Analytics
DIVIS LABORATORIES ₹255,115.0 Cr 2.6% 10.8% 57.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,613.0 Cr 2.7% 0.3% 39.6% Stock Analytics
CIPLA ₹112,876.0 Cr 2.4% -1.1% -12.6% Stock Analytics
DR REDDYS LABORATORIES ₹100,395.0 Cr 2.5% 0.8% -8.5% Stock Analytics


AJANTA PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AJANTA PHARMA

-0.8%

-0.6%

40%

SENSEX

-0.5%

-4.8%

-11%


You may also like the below Video Courses